Search

Literature can be useful in co-designing healthcare when transformed into a accessible and creative format. This study explores how a card tool developed from literature (Health Experience Insight Cards) can be used in healthcare co-design. The card tool was used in a pilot co-design workshop with six participants (Male=3, Female=3). Group A included people with only professional experience and Group B included people with a combination of personal and professional experience with diabetes. Both groups used the cards, in a storytelling activity to explore the patient experience. Interaction analysis identified three types of interaction that resulted from the storytelling activity: (a) applying the insight from the card to the character/story, (b) discussing real life and (c) discussing experiences. Differences in interactions were found between the two groups. An empathetic dialogue between stakeholders was developed by the group with only professional experience. Experience sharing was triggered between the group with professional and personal experience. The Health Experience Insight Cards offer a useful way to communicate insights from existing literature for use in co-designing health experiences. In our pilot study, the cards triggered discussion, enabled participants in the co-design workshop to discuss the health experience literature, related real-life issues and people's experiences. [ABSTRACT FROM AUTHOR]

With the rising cases of diabetes, more people are living with the complexity of this condition and calling for innovation and harmonisation of lifestyles, healthcare, technology and policy. This study explores the tension of this experience as a starting point to support the development of experience-focussed innovations for people living with diabetes. Existing experience literature was analysed through the previously designed Health Experience Insight Cards: Living with Diabetes Edition, previously developed by the authors. The cards were inductively sorted by the research team to understand the tensions within this experience. Five dimensions of tension were identified; (a) Person as expert and Doctor as expert, (b) Cost and benefit, (c) Medical ideals and Life priorities, (d) Quality of support and Quantity of support and (e) Stability and the Need for change. This research contributes to the field of health design through providing an exemplar of how in-depth research on a health experience can be collated, framed, presented as a tension tool and used in health experience design to embrace the complexity of living with diabetes. The tensions and the tool can be used by designers, health professionals, service providers and policymakers to evaluate and identify opportunities for experienced-centred health innovation. [ABSTRACT FROM AUTHOR]

Introduction: Fracture-related infection (FRI) is a serious complication related to orthopedic trauma, both from an infectious disease and a surgical point of view. The lack of scientific data with respect to diagnostic criteria and treatment principles of this entity has hampered efforts for an evidence-based approach and, as such, practices to prevent and treat FRI are often extrapolated from peri-prosthetic joint infection (PJI) literature. Recently, consensus guidelines were developed with respect to prevention, diagnosis and treatment of FRI.Areas covered: This review will define FRI and approaches to prevent and treat this complication will be discussed, with an emphasis on antimicrobial and surgical considerations. Guidelines focusing on FRI will be highlighted and aspects of pre-clinical research with imminent translational potential described.Expert opinion: New strategies are currently under investigation to improve the outcome of this sometimes-devastating complication. Local delivery of antimicrobials seems to be a promising approach; however, further high-quality clinical research is necessary to demonstrate efficacy. Delivery mechanisms for local antimicrobials include polymethyl methacrylate, implant coatings, collagen fleece, hydrogels and ceramics. The reintroduction of antimicrobials such as bacteriophage therapy has demonstrated promise in the management of drug-resistant organisms. [ABSTRACT FROM AUTHOR]